Skip to content

aTyr Pharma ATYR Asset turnover

Asset turnover at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
0.5×0.0×
Merck & Co. logo
Merck & Co.MRK
0.5×0.0×
United Therapeutics logo
United TherapeuticsUTHR
0.4×0.0×
Design Therapeutics, Inc. logo
Design Therapeutics, Inc.DSGN
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
0.9×-0.5×
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
0.4×+0.3×

Other financials

Income statement

See full
Revenue-
Operating income-$11.4M+27.5%
Net income-$10.8M+27.5%
EPS (diluted)-$0.11+35.3%

Balance sheet

See full
Cash & equivalents$10.0M-3.4%
Total debt$12.3M-9.2%
Total equity$57.9M-22.8%
Total assets$79.7M-18.1%

Cash flow

See full
Operating cash flow-$12.5M+18.8%
CapEx$138.0K
Free cash flow-$12.7M+17.9%

Valuation

See full
Market cap$54.88M-88.2%
Enterprise value$57.17M
P/S288.8×

Profitability

See full
Operating margin-40,856.3%+28,833pp
Net margin-39,009.5%+29,653pp
FCF margin-32,664.7%+4,018pp

Returns & leverage

See full
Return on equity-105.3%+50.6pp
Debt / equity0.2×0.0×
Current ratio5.8×-2.0×

Where this comes from

Calculated from aTyr Pharma’s reported figures.

Based on trailing twelve months.

The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about aTyr Pharma's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is aTyr Pharma's asset turnover?
aTyr Pharma (ATYR) reported asset turnover of 0× in Q4 2025.
How has aTyr Pharma's asset turnover changed year-over-year?
aTyr Pharma's asset turnover decreased by 9.1% year-over-year, from 0× to 0×.
What is the long-term trend for aTyr Pharma's asset turnover?
Over 4 years (2020 to 2025), aTyr Pharma's asset turnover has grown at a -70.9% compound annual growth rate (CAGR), from 0.3× to 0×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.